- Corporate Officers - L
- Lundbeckfond Invest A/s
Insider Trading History of Lundbeckfond Invest A/s
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lundbeckfond Invest A/s since 2014.
This trader's CIK number is 1591046.
At the time of last reporting, Lundbeckfond Invest A/s was the 10% Owner of Lexeo Therapeutics, Inc.. (stock ticker symbol LXEO).
Also see all insider trading activities at Lexeo Therapeutics, Inc..
Note that in the past
Lundbeckfond Invest A/S also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Eiger Biopharmaceuticals, Inc. (CLDN) by Lundbeckfond Invest A/s
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | CLDN | 182,681 | $1,461,448 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Enliven Therapeutics, Inc. (IMRA) by Lundbeckfond Invest A/s
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | IMRA | 187,500 | $3,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Trevi Therapeutics, Inc. (TRVI) by Lundbeckfond Invest A/s
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | TRVI | 375,000 | $3,750,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Io Biotech, Inc. (IOBT) by Lundbeckfond Invest A/s
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | IOBT | 2,142,857 | $29,999,998 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Lexeo Therapeutics, Inc. (LXEO) by Lundbeckfond Invest A/s
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | LXEO | 227,272 | $2,499,992 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Scpharmaceuticals Inc. (SCPH) by Lundbeckfond Invest A/s
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | SCPH | 654,762 | $9,166,668 | 0 | $0 | 0 | $0 |
Insider trading activities at 6 companies by Lundbeckfond Invest A/s:
1. Eiger Biopharmaceuticals, Inc. (CLDN)
2. Enliven Therapeutics, Inc. (IMRA)
3. Trevi Therapeutics, Inc. (TRVI)
4. Io Biotech, Inc. (IOBT)
5. Lexeo Therapeutics, Inc. (LXEO)
6. Scpharmaceuticals Inc. (SCPH)
Table 1. Insider trading of Eiger Biopharmaceuticals, Inc. (CLDN) by Lundbeckfond Invest A/s
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-02-04 | CLDN | Buy | 182,681 | 8.00 | 1,461,448 |
Table 2. Insider trading of Enliven Therapeutics, Inc. (IMRA) by Lundbeckfond Invest A/s
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-03-16 | IMRA | Buy | 187,500 | 16.00 | 3,000,000 |
Table 3. Insider trading of Trevi Therapeutics, Inc. (TRVI) by Lundbeckfond Invest A/s
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-05-09 | TRVI | Buy | 375,000 | 10.00 | 3,750,000 |
Table 4. Insider trading of Io Biotech, Inc. (IOBT) by Lundbeckfond Invest A/s
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-11-09 | IOBT | Buy | 2,142,857 | 14.00 | 29,999,998 |
Table 5. Insider trading of Lexeo Therapeutics, Inc. (LXEO) by Lundbeckfond Invest A/s
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-11-07 | LXEO | Buy | 227,272 | 11.00 | 2,499,992 |
Table 6. Insider trading of Scpharmaceuticals Inc. (SCPH) by Lundbeckfond Invest A/s
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-11-21 | SCPH | Buy | 654,762 | 14.00 | 9,166,668 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Lundbeckfond Invest A/s
(10% Owner of Lexeo Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.